Skip to main content
Clinical Trials/NCT00336687
NCT00336687CompletedNot Applicable

Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation.

University Hospital, Clermont-Ferrand1 site in 1 country322 target enrollmentStarted: July 2005Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
322
Locations
1
Primary Endpoint
Epidemiology of Thrombopenia and its consequences.

Study Overview

Brief Summary

About 40 % of the patients in reanimation are thrombopenics and the causes are not well known (reduction in platelet's production, increase in their destruction...). This protocol studies the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in order to bring patients best medical cares.

Detailed Description

About 40 % of the patients in reanimation are thrombopenics and the causes are not well known (reduction in platelet's production, increase in their destruction...). This protocol studies the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in order to bring patients best medical cares.

Study Design

Study Type
Observational
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Thrombopenia in reanimation

Exclusion Criteria

  • Pregnancy
  • Contraindication of myelogram

Outcomes

Primary Outcomes

Epidemiology of Thrombopenia and its consequences.

Time Frame: in reanimation

Secondary Outcomes

  • The impact of cost and mortality of Thrombopenia in reanimation.(in reanimation)

Investigators

Sponsor
University Hospital, Clermont-Ferrand
Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials

Study of Incidence, of Mechanisms and... | Clinical Trial